Clinical Trial Update: Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Jiedu Huayu Oral Prescription for intracranial hemorrhage in cerebral amyloid angiopathy; the study is currently not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Drugs mentioned

• Jiedu Huayu Oral Prescription

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Cerebral Amyloid Angiopathy | Phase 3 | Status: NOT_YET_RECRUITING